ArticleClinical cancer research : an official journal of the American Association for Cancer Research2011

Dual kinase inhibition of EGFR and HER2 overcomes resistance to cetuximab in a novel in vivo model of acquired cetuximab resistance.

Kelly M Quesnelle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.